text:
Mike Gallagher is a nationally syndicated radio host, Fox News Channel contributor and guest host, and author of the book "Surrounded by Idiots: Fighting Liberal Lunacy in America."
Why We Must Revisit The Iraq War
| Jack Kerwick
If You Like Your Internet, You Can Keep Your Internet. Actually No!
| George Landrith
Your 'To Do' List to Save America
| Ann Coulter
Smells and Politics
| Jackie Gingrich Cushman
Where Have All the Allies Gone?
| Victor Davis Hanson
Have You Heard About Hillary?
| Derek Hunter
On Domestic Violence, NFL Uses NOW's Playbook
| Larry Elder
Prayers and Preparation
| Mike Adams
An Idiotic Government with Idiotic Goals
| John Ransom
Why do Americans Hate America?
| Cal Thomas
Ukrainian President warns joint session of Congress of the 'new Cold War' | Noah Rothman
Open thread: Will Scotland declare independence? | Allahpundit
Syrian rebels openly admit: We're going to use America's money to fight Assad, not just ISIS | Allahpundit
VA: Actually, those secret wait lists did have something to do with the deaths | Ed Morrissey
TEMS Thursday: Duane Patterson, Alexandra Jaffe, Eliana Johnson | Ed Morrissey
Politics of man who sought to firebomb black congressman's office won't surprise you | Noah Rothman
Scotland Goes to the Polls for Independence Vote
Fighting Islamic State: House Approves Syria Plan
Illegal Alien Cartel Assassination Attempt In Texas
Little Boy Breaks Military Formation to Hug National Guard Mom
Iraq PM Says No Foreign Troops
Enthusiasm gap could be bad news for Mary Burke
| M.D. Kittle
Sasse stumbles on NRA question days after being endorsed
| Deena Winter
Happ's lead in AG race disappears amid property scandal
| M.D. Kittle
Townhall.com is the leading source for conservative news and political commentary and analysis.
Townhall is packed with breaking news headlines, political news, and conservative opinion with Townhall columnists including Ann Coulter, Michelle Malkin, Michael Barone, Star Parker, Dennis Prager, Thomas Sowell, and many more of your favorite conservatives.
Political cartoons full of satire and political humor from editorial cartoonists including Michael Ramirez, Glenn McCoy, and Henry Payne.
Townhall.com also features the latest news videos and pictures on the latest political hot topics including health care reform, the economy, immigration, government tax, President Obama, Sarah Palin, Mitt Romney, Herman Cain, Ron Paul, Iraq, immigration, politics, gay marriage laws, and many more big news issues.
Townhall Magazine is our monthly print magazine that offers more exclusive investigative journalism, in-depth reporting, analysis, interviews with the heavy hitters and powerful exposés.
Copyright © Townhall.com. All Rights Reserved. Terms under which this service
is provided to you


text:
15 U.S. Code § 77ggg - Qualification of indentures covering securities not required to be registered
(a) Application; information required; availability of information to public
In the case of any security which is not required to be registered under the Securities Act of 1933 [15 U.S.C. 77a et seq.] and to which subsection (a) ofsection 77fff of this title is applicable notwithstanding the provisions of section 77ddd of this title, an application for qualification of the indenture under which such security has been or is to be issued shall be filed with the Commission by the issuer of such security. Each such application shall be in such form, and shall be signed in such manner, as the Commission may by rules and regulations prescribe as necessary or appropriate in the public interest or for the protection of investors. Each such application shall include the information and documents required by subsection (a) ofsection 77eee of this title. The information and documents required by paragraph (1) of such subsection with respect to the person designated to act as indenture trustee shall be contained in a separate part of such application, which part shall be signed by such person. Each such application shall also include such of the other information and documents which would be required to be filed in order to register such indenture security under the Securities Act of 1933 as the Commission may by rules and regulations prescribe as necessary or appropriate in the public interest or for the protection of investors. An application may be withdrawn by the applicant at any time prior to the effective date thereof. Subject to the provisions of section 77uuu of this title, the information and documents contained in or filed with any application shall be made available to the public under such regulations as the Commission may prescribe, and copies thereof, photostatic or otherwise, shall be furnished to every applicant therefor at such reasonable charge as the Commission may prescribe.
(b) Filing of application
The filing with the Commission of an application, or of an amendment to an application, shall be deemed to have taken place upon the receipt thereof by the Commission.
(c) Applicability of other statutory provisions
The provisions of section 77h of this title and the provisions of subsection (b) ofsection 77eee of this title shall apply with respect to every such application, as though such application were a registration statement filed pursuant to the provisions of the Securities Act of 1933 [15 U.S.C. 77a et seq.].
Source(May 27, 1933, ch. 38, title III, § 307, as added Aug. 3, 1939, ch. 411, 53 Stat. 1156; amended Pub. L. 107–123, § 7,Jan. 16, 2002, 115 Stat. 2397.)
References in Text
The Securities Act of 1933, referred to in subsecs. (a) and (c), is act May 27, 1933, ch. 38, title I, 48 Stat. 74, as amended, which is classified generally to subchapter I (§ 77a et seq.) of this chapter. For complete classification of this Act to the Code, see section 77a of this title and Tables.
2002—Subsec. (b). Pub. L. 107–123substituted "Commission" for "Commission, but, in the case of an application, only if it is accompanied or preceded by payment to the Commission of a filing fee in the amount of $100, such payment to be made in cash or by United States postal money order or certified or bank check, or in such other medium of payment as the Commission may authorize by rule and regulation".
Effective Date of 2002 Amendment
Amendment by Pub. L. 107–123effective Oct. 1, 2001, see section 11 ofPub. L. 107–123, set out as a note under section 78ee of this title.
Transfer of Functions
For transfer of functions of Securities and Exchange Commission, with certain exceptions, to Chairman of such Commission, see Reorg. Plan No. 10 of 1950, §§ 1, 2, eff. May 24, 1950, 15 F.R. 3175, 64 Stat. 1265, set out under section 78d of this title.
The table below lists the classification updates, since Jan. 3, 2012, for this section. Updates to a broader range of sections may be found at the update page for containing chapter, title, etc.
The most recent Classification Table update that we have noticed was Tuesday, August 13, 2013
An empty table indicates that we see no relevant changes listed in the classification tables. If you suspect that our system may be missing something, please double-check with the Office of the Law Revision Counsel.
|Description of Change
|Session Year
|Public Law
|Statutes at Large
LII has no control over and does not endorse any external Internet site that contains links to or references LII.

subset: commoncrawl


text:
p53 Gene May Help Fight Tumors
Drug developers have long wondered whether p53, one of the most commonly mutated genes in cancer, would make a good target for cancer therapies. Three new studies in mice suggest that it might.
The gene normally helps suppress tumors, and many cancer patients are thought to acquire p53 mutations relatively early in the disease. It has not been known whether these mutations also contribute to cancer later on, once tumors have been established. Read more
Guest Update by Dr. Dinah Singer
Breast Premalignancy Research Bolstered by Database on Healthy Tissue
Developing a better understanding of the healthy breast is critical to our efforts to identify biomarkers and other diagnostic and therapeutic tools for use against early breast cancer. At last week's steering committee meeting of the NCI Breast Cancer Stamp Premalignancy Research Program, we heard about a new program that addresses the key issue of our limited understanding of the biology and normal developmental genetics of the mammary gland.
The "Friends for Life" project is an effort of the Indiana University (IU) Breast Program, the Catherine Peachey Fund, Inc., and the IU Cancer Center to create a collection of voluntarily donated breast tissue, blood, and macromolecules derived from blood and saliva of healthy donors. The undertaking is a collaboration among consumer advocates, clinicians, basic scientists, and volunteers. "Friends for Life" was created in response to a need articulated by scientists carrying out breast cancer research - in order to better understand what is abnormal in breast cancer, the breast's normal state needs to be more clearly defined. Read more
p53 Gene May Help Fight Tumors
Drug developers have long wondered whether p53, one of the most commonly mutated genes in cancer, would make a good target for cancer therapies. Three new studies in mice suggest that it might.
The gene normally helps suppress tumors, and many cancer patients are thought to acquire p53 mutations relatively early in the disease. It has not been known whether these mutations also contribute to cancer later on, once tumors have been established.
The mouse studies suggest that they do. The researchers tested this idea by creating mice with p53 genes that could be turned on and off. They allowed the mice to develop cancers before turning on the gene. When they activated p53, the results were dramatic.
Tumors disappeared as cancer cells died or stopped growing, sometimes within hours. In one study, mice with large tumors died because the anticancer response was so strong. Even restoring p53 for a short time caused tumors to disappear.
"The tumors went away when we activated p53," says Dr. Scott Lowe of Cold Spring Harbor Laboratory in New York. His group studied mice with a form of liver cancer, and their results appeared online in Nature on January 24.
Each group used different methods to study different tumors. But they all concluded that at least some tumors depend for their survival on blocking the p53 gene and the genetic program, or pathway, it controls.
"The p53 pathway must be kept silent in established tumors for their viability," says Dr. Tyler Jacks of the Massachusetts Institute of Technology, who led a companion study in Nature. "The pathway appears to remain important even in advanced tumors."
If the same is true in human cancers, then a potential therapy may be to reactivate a damaged p53 gene. The new results make this scenario seem plausible.
"The key point is that when you restore p53 in established cancer cells, the gene is engaged in the pathway," says Dr. Gerard Evan of the University of California, San Francisco, who led the third study. Their findings appeared in Cell on December 29, 2006.
"This is incredibly good news because it means that mending a lesion in the p53 pathway would restore the body's natural ability to kill or block the growth of tumors," says Dr. Evan.
The signals that activate p53 and lead to an antitumor response are specific to cancer cells. This means that restoring p53 is unlikely to have effects on normal tissues, and this was the case in most of the mouse experiments.
"These studies really do formally establish once and for all that the p53 pathway is a good therapeutic target," says Dr. Lowe. Developing ways to restore defective genes in cells will not be easy, he adds, but efforts are underway.
The mechanisms by which the cancers regressed varied with the tumors. Dr. Jacks' team found that lymphoma cells died while sarcoma cells stopped growing. In Dr. Lowe's study, the immune system played a role in causing liver tumors to regress.
Dr. Evan's group provides a cautionary note - the lymphomas they saw regress eventually returned. But the researchers are learning why this happened, and they remain optimistic.
"I believe that restoring p53 in human cancers is going to have a profound therapeutic effect that will be specific to cells with abnormal p53," says Dr. Evan.
By Edward R. Winstead
Guest Update by Dr. Dinah Singer
Breast Premalignancy Research Bolstered by Database on Healthy Tissue
Developing a better understanding of the healthy breast is critical to our efforts to identify biomarkers and other diagnostic and therapeutic tools for use against early breast cancer. At last week's steering committee meeting of the NCI Breast Cancer Stamp Premalignancy Research Program, we heard about a new program that addresses the key issue of our limited understanding of the biology and normal developmental genetics of the mammary gland.
The "Friends for Life" project is an effort of the Indiana University (IU) Breast Program, the Catherine Peachey Fund, Inc., and the IU Cancer Center to create a collection of voluntarily donated breast tissue, blood, and macromolecules derived from blood and saliva of healthy donors. The undertaking is a collaboration among consumer advocates, clinicians, basic scientists, and volunteers. "Friends for Life" was created in response to a need articulated by scientists carrying out breast cancer research - in order to better understand what is abnormal in breast cancer, the breast's normal state needs to be more clearly defined.
A partnership of patient advocates and clinicians eagerly accepted the challenge of developing a bank of normal tissue. The response of the community to the request for volunteers has been overwhelmingly enthusiastic. The tissue bank is currently the repository of more than 2,500 specimens collected over a 2-year period, including specimens from women participating in the annual Susan G. Komen "Race for the Cure" in Indianapolis. All specimens are annotated with detailed information about the donor; most are from women without evidence of breast cancer.
Dr. Anna Maria Storniolo, director of the Catherine Peachey Breast Cancer Prevention Program at the IU Cancer Center and the principal investigator on the project, described the three primary components of "Friends for Life:" 1) the blood and tissue collection procedures; 2) the repository of blood, DNA, and frozen human breast tissue which, in the future, will also contain plasma and RNA; and 3) a Web-based database that can be queried with regard to available specimens and the attributes of the specimens' donors.
This online database will be available later this year and will include additional information on the tissue bank, the standard operating procedures used for specimen collection, and instructions on how to request and obtain tissue.
The uses of normal breast tissue are myriad and include, for example, the isolation of RNA for gene microarrays, the inclusion of these tissues on tissue microarrays, and the cataloging of the epigenetic regulation of normal breast tissue. Annotated DNA from this project has already been utilized to identify single nucleotide polymorphisms associated with hot flashes.
The "Friends for Life" project is an important complement to NCI's Breast Cancer Premalignancy Program, which we think may lead to real advances in understanding and intervening in the early biological events associated with breast cancer premalignancy.
Arsenic Trioxide Improves Survival in Adults with APL
Recent results from a Cancer and Leukemia Group B (CALGB) phase III clinical trial showed that adult patients with acute promyelocytic leukemia (APL) who received arsenic trioxide (Trisenox) in addition to standard chemotherapy had significantly better event-free and overall survival than those who received only standard chemotherapy.
The NCI-sponsored CALGB study tested the effects of arsenic trioxide on 582 patients between June 1999 and March 2005. Patients with newly diagnosed APL, an uncommon form of leukemia, were randomly assigned to one of two treatment groups. The standard remission treatment group received the chemotherapy drugs daunorubicin and cytarabine with twice daily doses of all-trans retinoic acid (ATRA) followed by the standard postremission regimen of two more courses of ATRA plus daunorubicin. The experimental treatment group received the same standard treatment with the addition of two courses of arsenic trioxide given immediately after the patient entered a complete or partial remission and before the standard postremission regimen.
The researchers found that 77 percent of those adult patients in the combined chemotherapy and arsenic trioxide treatment group remained in remission 3 years after diagnosis compared to 59 percent of patients receiving only the standard treatment. In addition, 86 percent of adult patients on the combined chemotherapy and arsenic trioxide treatment regimen were still alive after 3 years compared to 77 percent of patients on the standard treatment.
Study co-investigator Dr. Richard Larson from the University of Chicago noted, "These results indicate that arsenic trioxide should be considered as part of the initial treatment of patients with acute promyelocytic leukemia."
Radiation After BCS Benefits Older Women with Breast Cancer
A study from the NCI-sponsored Cancer Research Network published online in Cancer on January 22 has shown that women aged 65 or older who receive radiation therapy after breast-conserving surgery (BCS) and 5 years of tamoxifen therapy have a reduced risk of cancer recurrence compared with those who do not receive these standard treatments.
Investigators led by Dr. Ann M. Geiger of Wake Forest University searched the medical records at six HMOs in the Cancer Research Network for women aged 65 or older who underwent surgery for early-stage breast cancer between 1990 and 1994. They recorded whether women had a full mastectomy, BCS followed by radiation therapy, or BCS alone. They also recorded the incidence and duration of tamoxifen use in women with hormone-receptor-positive tumors.
After adjusting for known prognostic variables, the investigators found that women who underwent BCS without radiation therapy had an increased risk of recurrence or second primary breast cancer compared with women who had a full mastectomy. In contrast, women who received radiation therapy in addition to BCS did not have an increased risk of either recurrence or a second primary cancer. Women with hormone-receptor-positive tumors who received 5 or more years of tamoxifen therapy were less likely to have a recurrence or second primary cancer than women who received tamoxifen for less than a year.
Radiation therapy following BCS and tamoxifen benefited women regardless of age, race, ethnicity, or comorbidities. Because several recent studies have shown that older women are less likely to receive standard cancer therapies, the authors stress "the importance of providing high-quality cancer care to all patients, regardless of age."
Study Confirms Cigarettes Packing More Nicotine Punch
Cigarette smoke-nicotine yields increased 11 percent between 1998 and 2005. That is the conclusion of a new report from the NCI-supported study by the Tobacco Research Program at the Harvard School of Public Health (HSPH), which analyzed data from the nation's major tobacco manufacturers.
The new report echoes findings from a similar report released last summer by the Massachusetts Department of Public Health. Massachusetts law requires all manufacturers of cigarettes sold in the state to provide a comprehensive annual report on nicotine yield and other measures of cigarettes design. Smoke-nicotine yields are measured using a standardized machine-generated method that compares cigarettes, regardless of individual smoking behavior.
The researchers identified two ways the cigarette manufacturers appear to have increased the smoke-nicotine yield: a higher concentration of nicotine in the tobacco rod (the portion of the cigarette that holds the majority of the tobacco) and a reduced "burn rate," which permits more puffs per cigarette. The researchers cautioned that these two factors could not account for the total increase seen and that "precise information about these products remains shrouded in secrecy, hidden from the public."
"Our findings call into serious question whether the tobacco industry has changed at all in its pursuit of addicting smokers since signing the Master Settlement Agreement of 1998 with the State Attorneys General. Our analysis shows that the companies have been subtly increasing the drug nicotine year by year in their cigarettes, without any warning to consumers since the settlement," said the study's lead author, Dr. Gregory Connolly, a professor of the practice of public health at HSPH.
The study authors note that "all cigarettes are highly addictive and deadly, and relatively minor changes in nicotine yield may not significantly alter the product's addictive properties." They suggest that the increased nicotine may be intended to make it easier for smokers to maintain their addiction, including lower income smokers who may be smoking fewer cigarettes as the price of tobacco products increases.
Women May Be Quitting Tamoxifen More Often than Thought
When women who have early-stage, hormone-responsive breast cancer take adjuvant tamoxifen for 5 years, it can dramatically reduce their risk of breast cancer recurrence and death. But sometimes women stop the treatment early and forgo these benefits. A study published online January 22 in Cancer reveals that the number of women who do this may be higher than previously thought.
Researchers at St. James's Hospital in Dublin analyzed records from a national database that logs prescriptions filled through the Irish government's free health care system, which serves approximately one-third of the country's population. The final study cohort included 2,816 women over the age of 35 who had filled tamoxifen prescriptions between January 2001 and January 2004.
Previous studies have estimated the rate of nonpersistence, or discontinuing treatment with tamoxifen, at between 16 and 32 percent within 5 years. The current study, which is the largest thus far, showed that the discontinuation rate was 35.2 percent after a follow-up of just 3.5 years. "It is likely that persistence with tamoxifen will have declined further by the time the cohort of patients in this study has completed 5 years of treatment," the authors warn. Some factors associated with nonpersistence included younger age (under 44) and older age (over 75).
The authors speculate that younger women may have difficulty accepting a diagnosis of breast cancer and thus may be less accepting of tamoxifen's side effects. They also note that because some types of antidepressants have been shown to decrease severe hot flashes, these drugs may improve persistence by minimizing side effects.
SWOG Closes Prostate Cancer Trial
The NCI-sponsored Southwest Oncology Group (SWOG) last week announced that it has closed a phase III prostate cancer treatment clinical trial because the new treatment under investigation was associated with a rare but dangerous side effect.
The trial, dubbed S9921, was designed to see whether hormone-deprivation therapy combined with the chemotherapy drug mitoxantrone was superior to hormone-deprivation therapy alone in men with "poor risk" prostate cancer - that is, cancer that had spread beyond the prostate and was at high risk of recurring after surgery or radiation therapy.
Mitoxantrone has already been approved by the Food and Drug Administration for the treatment of advanced prostate cancer. Of the 983 patients enrolled in the trial, 488 had received mitoxantrone as part of their treatment. In the most recent review of survival and side-effect data from the trial, SWOG explained in a statement, trial leaders noted three cases of acute myelogenous leukemia among the patients who had received mitoxantrone. No patients in the hormone deprivation-only group developed leukemia.
Following a review and recommendation from SWOG's Data Safety Monitoring Committee, the trial was closed.
CA125: Biography of an Ovarian Biomarker
For most ovarian cancer patients, however, the disease has begun to spread by the time it is detected, and only one in four patients with advanced ovarian cancer will be alive 5 years after diagnosis.
Ovarian cancer also provides the context for another story: the role of biomarkers in cancer research. A cancer biomarker is a substance in the body that - by its presence, pattern, or behavior - alerts clinicians to hidden biologic activity that might be associated with some aspect of the precancerous or neoplastic process.
For many years, a protein known as CA125 has been a prominent blip on researchers' radar screens. The history of CA125 illustrates the promise and the challenges involved in the search for a biomarker that could lead to meaningful clinical progress in fighting ovarian cancer.
The Early Years
After the development of monoclonal antibody technology in 1975, many scientists began the search for antibodies that would react with specific tumor tissue types. One of those researchers was Dr. Robert C. Bast, who would go on to become vice president for translational research and the principal investigator for the Ovarian SPORE at the University of Texas M.D. Anderson Cancer Center.
In the late 1970s, Dr. Bast and colleagues used the then new monoclonal technology to develop antibodies against human ovarian cancer, and their 125th hybridoma produced an antibody that would bind to antigens expressed by about 80 percent of epithelial ovarian cancers (which comprise about 90 percent of all ovarian cancers). They named it OC-125 and by 1983 Dr. Bast's group reported the first clinically usable, monoclonal antibody radioimmunoassay to monitor the response of epithelial ovarian cancer to treatment, known as the CA125 test.
Equipped with a test for an antigen that epithelial ovarian cancer cells shed into the blood, researchers wondered if they had a potential screening test.
"To stand alone as a screen for ovarian cancer, a biomarker would have to detect significantly more cases at the early, highly curable stage than the 28 percent we find now. We need a sensitivity of at least 80 percent," says Dr. Beth Karlan.
Dr. Karlan is director of the Gilda Radner Hereditary Cancer Detection Program at Cedars Sinai's Women's Cancer Research Institute in Los Angeles. Since a positive test could lead to abdominal surgery, its positive predictive value needs to be at least 10 percent. "You also want to avoid false-positives in a relatively rare disease, and so the specificity should exceed 99 percent," she explains.
The CA125 test did not meet this threshold, in part because elevated CA125 levels were also found in patients with other types of cancer, and also in several benign conditions; only about 3 percent of patients with elevated CA125 actually had previously undetected ovarian cancer. "Nonetheless we knew we had a potential tool, it was just a matter of learning how to use it," notes Dr. Bast.
Coming of Age
"A prognostic biomarker is something we can measure that correlates to disease outcome," explains Dr. Gary Kelloff, special advisor to NCI's Cancer Imaging Program in the Division of Cancer Treatment and Diagnosis. "If a cellular protein like CA125 can stand in as an effective surrogate for the standard way we measure how ovarian cancer responds to chemotherapy, it could economize and hasten the process of testing new drugs."
In advanced ovarian cancer, surgery to remove all detectable disease is the first-line treatment, usually followed by chemotherapy administered directly into the peritoneum. Unfortunately, most patients eventually see their disease recur and progress. The standard way to mark such recurrence is the Response Evaluation Criteria in Solid Tumors (RECIST) criteria, which rely on imaging to detect a visible mass.
"But when ovarian cancer does recur, CA125 sends us a message about 3 months before we could detect it in any other way," says Dr. Bast.
Since the late 1980s, Dr. Gordon J.S. Rustin has been conducting a series of clinical trials on how to translate this early warning signal most accurately, since many clinicians were monitoring CA125 levels but interpreting them differently. The Gynecologic Cancer Intergroup (GCIG), formed in 1997, joined many of the cooperative groups into a common organization to foster collaboration and consensus.
By 2006, GCIG had agreed on definitions for measuring response and progression. While there may still be a few final issues to resolve, Dr. Rustin believes it is crucial to have the most accurate early date of progression established uniformly in clinical trials. He and others are working to validate the GCIG standard. "A comprehensive analysis of emerging data on CA125 may lead regulatory agencies to adopt it into their thinking about drug development and drug approval," says Dr. Kelloff.
A Crucial Tool
The CA125 assay has twice been refined, and now serves as a versatile tool for ovarian cancer clinicians. It fills several important roles, not to mention its revived prospects as part of a multistep screening approach.
Transvaginal ultrasound (TVU) and color power Doppler imaging can sometimes distinguish a benign from a malignant pelvic mass. A new model incorporates CA125 levels into an imaging approach that has a specificity of greater than 99.6 percent and a sensitivity of more than 70 percent in detecting malignancy, providing the required 10 percent predictive value.
Tumor response and progression are also markers of a patient's prognosis that CA125 testing can measure. The half-life of CA125 is about 14 days following initial surgical resection and the beginning of chemotherapy. Persistent disease that may not be detected by imaging, however, extends this time to more than 20 days, correlating with a poor prognosis.
Dr. Kelloff suggests that CA125 could play an important role in clinical trial design. For example, when used in all arms of a randomized trial, CA125 could signal an earlier time to stop ineffective drug combinations.
"The potential value is great," adds Dr. Rustin. "Patients identified by CA125 can be included in phase II trials, even though they would not have qualified using RECIST. The go/no-go decisions to keep drugs moving through the pipeline can be reached more quickly and economically in many cases."
And back to screening, where it all began for CA125. "Currently, we combine CA125 and TVU and focus on women with a strong family history of ovarian cancer or early-onset breast cancer," says Dr. Karlan. NCI's large PLCO clinical trial is investigating these two screening tests in a general population of older women.
Molecular and genetic research is starting to uncover more specific signatures of the early stages, says Dr. Karlan, who credits NCI's Early Detection Research Network for useful guidelines to develop new biomarkers for screening.
"I expect an effective screen for ovarian cancer to emerge by 2015," predicts Dr. Bast. "And when it does, CA125 may still be one of its integral features."
By Addison Greenwood
Sorafenib for Kaposi's Sarcoma
Name of the Trial
Principal Investigator
Why This Trial Is Important
Because blood vessel growth is a central component of KS tumors, researchers believe that drugs targeting blood vessel growth may be effective in treating KS. In this trial, patients with either AIDS-related or non-AIDS-related KS will take varying doses of the drug sorafenib (Nexavar) for up to 54 weeks. Sorafenib is a new type of targeted drug that blocks the activity of several proteins that are important for cell division and for the growth of new blood vessels (angiogenesis).
Researchers will examine the safety of the drug and determine how the drug is processed in patients with KS who are receiving antiretroviral therapy for human immunodeficiency virus (HIV) infection and in those who are not receiving such treatment. Certain protease inhibitors that are used to treat HIV can affect the metabolization of sorafenib.
"Sorafenib blocks several molecular pathways important for the growth of KS," said Dr. Yarchoan, "so we have a good rationale for using this FDA-approved drug [for kidney cancer] in patients with KS. Additionally, we are exploring the potential interactions between sorafenib and the antiretroviral drug ritonavir, which is often used to treat patients infected with HIV-1."
Who Can Join This Trial
Study Site and Contact Information
An archive of "Featured Clinical Trial" columns is available at http://cancer.gov/clinicaltrials/ft-all-featured-trials.
Dr. Sanya A. Springfield Appointed Director of CRCHD
Prior to joining CRCHD, Dr. Springfield served as chief of NCI's Comprehensive Minority Biomedical Branch where she led activities to increase the number of competitive minority researchers involved in cancer research, including the Continuing Umbrella of Research Experiences program.
If Memory Serves...
The NIH campus was erected in Bethesda, MD, on 45 acres of land that had been donated to the government by Mr. and Mrs. Luke Wilson. (Read more)
For more information about the birth of NCI, go to http://www. cancer.gov/aboutnci/ncia.
caBIG Annual Meeting Slated for February
There is no charge for the conference, but participants should register on the meeting Web site, https://cabig.nci.nih.gov/2007caBIGconference, if they plan to attend.
Following are newly released NCI research funding opportunities:
Monograph Highlights New Malignancies Among Cancer Survivors
Researchers from NCI's Division of Cancer Epidemiology and Genetics (DCEG) and Division of Cancer Control and Population Sciences (DCCPS) recently published a monograph, New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. The monograph is the first publication to provide a comprehensive analysis of the risk for U.S. cancer survivors of developing a new malignancy.
"This is by far the largest study to date to assess risk of subsequent cancers. It includes more than 2 million cancer survivors during a nearly 30-year period and more than 185,000 subsequent primary cancers," said lead editor Rochelle Curtis of DCEG's Radiation Epidemiology Branch. "Other studies have evaluated risk of subsequent cancers for individual cancer types or groups of cancers, usually related to the late effects of treatment, but this report provides the first complete evaluation of subsequent cancer risk in the U.S. for most first primary cancer sites."
The report used data from nine cancer registries participating in the Surveillance, Epidemiology, and End Results (SEER) Program from 1973 to 2000.
"This report adds a new dimension to cancer surveillance in that it pinpoints which cancers are more likely to be followed by another primary. This knowledge is possible because of the depth of information from almost 30 years of consistently reliable SEER data," noted co-editor Lynn Ries of DCCPS's Cancer Statistics Branch.
More than 50 adult and 18 childhood cancers were evaluated in the new report, which includes new data on less common cancer sites. More than 350 data tables present the risk of subsequent cancer by time since initial diagnosis, sex, age at initial diagnosis, and when appropriate, by treatment and cancer cell type. Each chapter compares the findings with other published studies and discusses the results in terms of potential risk factors and mechanisms.
Overall, the results showed that cancer survivors have a 14-percent increased risk of developing a subsequent cancer than would be expected in the general population. Many of the patterns of multiple cancers suggested an effect of shared risk factors (such as tobacco and alcohol consumption, nutritional factors, hormones, infections and immunosuppression, and genetic predisposition) or a carcinogenic effect of cancer therapies. Although a sizable portion of multiple cancers in the SEER database represented tumors that occurred in the same or neighboring organ systems, most of the subsequent cancers occurred in diverse organ sites.
One of the most striking findings was that tobacco smoking, excess alcohol intake, or the interaction of the two exposures appeared to account for more than 35 percent of the excess cancer risk observed in the survivor population.
"This effort represents an important collaboration between two NCI divisions," said Dr. Joseph F. Fraumeni, Jr., DCEG director and senior editor of the monograph. "It should provide a tremendous resource for clinicians, researchers, and other health professionals, and it should be useful in alerting cancer survivors to the importance of medical supervision for prevention and early detection of new malignancies."
The monograph may be viewed or ordered at http://seer.cancer.gov/publications/mpmono/.


text:
We put together a plan for dinner when we heard traveling wine geek Matt L would be in town. Matt had his trip postponed, but we went ahead with the dinner anyway.
Several of the locals met at the Old World Deli last evening with the theme of wines Matt would like.
With oysters on the half shell (Pacific and Kumamotos) we opened a 1989 Luneau-Papin Muscadet de Sèvre-et-Maine Sur Lie Le "L" d'Or and a 2006 François Raveneau Chablis 1er Cru Forêt. The L d'Or was a good bottle, slightly darker yellow in color then a new vintage but not full gold. The nose was dominated by lees and yeast, with suggestions of sweet stone fruit at least in the aroma. The mouth emphasized wet rock mineral flavors over any fruit. This bottle had less cut and drive then prior ones I've tried, but still going pretty strong. Any night there is a Raveneau is a real treat. This bottle to me showed that great producers make the most of tough vintages. Lemon zest, lemon oil nose, and the mouth and structure seemed fairly full for Chablis, lowish acids, big mineral side. The structure reminded me a little of a white Rhone. Persistent finish, and opened a lot with air. I thought it was great, but have no idea how it will age from here. Both were good with the oysters, the lemon citrus flavor of the Chablis was my favorite match.
With duck liver pate and a pork/black truffle/mushroom pate we drank a 2007 Houillon Overnoy Poulsard Arbois. This was a pale washed out red color. The nose was great, pure, clean and very expressive. A little VA, but not much dirt. Red fruit mainly. The mouth was a bit rustic with a tiny bit of prickly CO2 and rough acids. Beautiful aroma, very young structure. Nice wine with the pate.
2007 Jean Foillard Morgon Côte du Py Cuvée 3.14 helped finish up the pate and bridge into the next course of wild mushroom soup. The wine seemed young, fully open, with gorgeous deep Morgon fruit and spice with the structure buried under the primary fruit. Great bottle, with a nice future I would guess.
1989 Chateau de la Gardine Chateauneuf du Pape came in a squat shaped bottle but was a very fine mature drink. Nose was sour cherry and garrigue, with some lift from remaining acidity in the mouth and the tannins resolved. It faded pretty quick, but was a nice sip. The back of the bottle said Brunel family. I know little about this but would guess it had a fair amount of Mourvedre in it.
2 younger Rhone wines were opened next to go with a hearty Coq au vin with chanterelles and house made bacon. 2001 Charvin Chateauneuf du Pape had a funky bottle bouquet on opening but with air blew off to an elegant mix of raspberry and some smoke, nice compact structure, and no heat. Not a blockbuster, but understated and pretty, and just getting into some tertiary flavors. The 2001 Allemand Cornas Reynard smelled awful when I opened it a few hours before dinner, highly reduced, burnt rubber with vanilla oak under the stink. A couple hours in a decanter really helped. Still some smoke, meaty, blackberry aromas. Structure was very fine grained tannins and great acidity. I didn't notice much pepper or olive in this bottle. Very young Cornas but even now delicious. Fabulous with the bacon bits and wine soaked chicken. I liked these two bottles a lot, but would wait on opening any more of them for a while.
There was a 2005 Delas Frères Hermitage that I didn't spend much time with. It seemed very fruit forward and new worldish, but it might have been just too young.
2002 Huët Vouvray Demi-Sec Le Haut-Lieu was a medium yellow color. It had the craziest nose of raw oyster juice at first, and I tried another pour in a different glass to see if the glass was tainted, but it was there in both glasses! This thankfully went away soon and left a honeyed, wet straw, more typical smell in its wake. The mouth was pleasant, with a nice balance of extract, acidity and sugar. One taster thought it could have used a bit more cut, but for me it was just about right. The initial aromas were pretty weird though.
There was a 2004 Fourrier Gevrey-Chambertin Aux Echezeaux opened toward the end of the evening that I liked. Not much green, a mix of earth and fruit and seemed maybe a bit advanced for its age. I wasn't giving it the attention it really deserved at that point.
Hopefully we will get to drink with Matt sometime in the future, but thanks for giving us the prompt to do this dinner. We missed you Jenise!


text:
- Drop a Hundy On It!
$99.99Free with:
100CLUB LAX Points
Hit the field with the new featherweight champion of lacrosse gloves. The super light backhand design has increased venting and flexibility offering optimal protection. Dual material zones with two tone knit nylon minimize weight. Cuff design allows for maximum wrist bend to increase flexibility.
Lamentamos que todavia no hay descripción en español para este producto.


text:
Tablecraft focuses manufacturing their products around what customers want. Tablecraft makes smallwares that will complete any chef's kitchen collection. KaTom sells top quality Tablecraft products for affordable prices. No matter your need for kitchen utensils, buffetware, or coffee supplies KaTom has you covered with the excellence that is Tablecraft.
Your Tablecraft dispenser, high chair, bar service products, and table service needs are ready to be met by the quality experts at KaTom Restaurant Supply.
Tablecraft Table Service
Keep your restaurant's tables looking great with Tablecraft table service products from KaTom Restaurant Supply. KaTom's selection of Tablecraft table service products features everything from baskets for serving to attractive table signs that are ideal for reservations. These Tablecraft restaurant table service products are priced to sell at affordable costs! Choose the best Tablecraft restaurant table service products for your food service establishment by shopping with KaTom.
Tablecraft Buffetware
Your buffet will look like a million bucks after you've stocked it with Tablecraft buffet supplies from KaTom Restaurant Supply! KaTom Supply's selection of Tablecraft buffet supplies contains helpful products like appetizer plates, beverage tubs, and much more! No matter your needs, you can be sure KaTom has the Tablecraft buffet ware for you! Feel free to browse this fine collection of Tablecraft buffet ware for the products your restaurant buffet needs!
Tablecraft Dispensers
Find the dispensers your food service establishment can't do without by browsing KaTom's section of high quality Tablecraft dispensers. This collection of Tablecraft dispensers features models for beverages as well as straws and condiments so no matter your needs, KaTom has you covered. KaTom Restaurant Supply passes the savings on to you with affordably priced Tablecraft food dispensers. Find the Tablecraft food dispensers your business needs today with KaTom.
Tablecraft Bar Service
Stock your bar with Tablecraft commercial bar supplies from KaTom Restaurant Supply! In this great selection of Tablecraft commercial bar supplies you're sure to find every tool from portion pourers to attractive insulating wine coolers. Worried about the cost? Don't fear, KaTom Supply is here with competitive pricing on Tablecraft bar supplies! Make your Tablecraft bar supply purchase today and save with KaTom today!
Tablecraft Kitchen Utensils
Decrease the amount of effort food prep takes with the right Tablecraft kitchen utensils! KaTom Restaurant Supply carries Tablecraft kitchen utensils like tongs, skewers, and colanders that will efficiently speed up food preparation, reducing the amount of time it takes for your customers to receive their order. Tablecraft chefs tools are priced affordably with your budget in mind. Make your Tablecraft chefs tools purchase today with KaTom Supply!
Tablecraft Miscellaneous
Tablecraft has a variety of restaurant accessories that can be used to round out an already well rounded inventory! Such as Tablecraft fry baskets which can be used to make tacos as well as French fries. Don't forget about our Tablecraft restaurant dispensers that can be used in a variety of different ways! Find whatever Tablecraft Miscellaneous items you need at KaTom Restaurant Supply!
Tablecraft Kitchen Supplies
Find all of the Tablecraft kitchen supplies you've been looking for with KaTom Restaurant Supply. Tablecraft kitchen supplies are affordable yet durable enough to last in commercial settings so you don't have to worry about breaking your budget. You'll quickly see that KaTom carries a wide selection of Tablecraft commercial kitchen supplies like food boxes that will make cooking even easier. Take a look through KaTom's selection of Tablecraft commercial kitchen supplies today!
Tablecraft Cash N Carry Items
Find the products your establishment needs in KaTom's Tablecraft cash and carry tableware selection. Because Tablecraft cash and carry tableware pieces from KaTom are pre-packaged you don't have to worry about the merchandising aspect of product re-selling! When you look through the Tablecraft cash and carry smallware section you're sure to find everything from squeeze dispensers to pepper shakers. Find the Tablecraft cash and carry smallwares your store needs with KaTom.
Tablecraft Warewashing Silverware Cylinders & Bins
Every restaurant or catering company has to have silverware for their guests, which means it also needs to be washed. That's where Tablecraft silverware bins come in! Tablecraft silverware bins are highly durable and easy to store off to the side! Tablecraft silverware trays are a great way to keep your silverware organized during those busy rushes! Shop KaTom Restaurant Supply for Tablecraft silverware trays and bins!
Tablecraft Coffee Service
A great addition to any office or hotel lobby, Tablecraft coffee service gives you everything you need to get going! Tablecraft commercial coffee service is also great for any restaurant or catering company! Giving you all the supplies you need to provide your guest or employees with a wonderful experience, Tablecraft commercial coffee service is a must have! Find the full line of Tablecraft coffee service supplies at KaTom Restaurant Supply!
Tablecraft High Chairs & Booster Seats
Families can be large part of any restaurants clientele and Tablecraft high chairs can be very helpful for families with small children! Tablecraft booster seats are a great addition to any restaurant and can make the guest feel right at home! Tablecraft booster seats are durable and compact for easy storage. Shop KaTom Restaurant Supply for Tablecraft high chairs and booster seats!
Tablecraft Signage
Your restaurant needs signs and we have them! Tablecraft commercial signage is a great way to inform your guests on what is and is not permitted in your establishment! Tablecraft restaurant signage has everything you need to inform your guests on where things are located within your establishment! Everything from no smoking signs to exit signs and anything in between! Tablecraft commercial restaurant signage is available at KaTom Restaurant Supply!


text:
Software Map
Tag cloud | Project Tree | Project List
Project tree
Now limiting view to projects in the following categories:
Programming Language :: C [Remove This Filter]
License :: OSI Approved :: GNU General Public License (GPL) [Remove This Filter]
Operating System > POSIX
Browse By:
7 projects in result set.
|0. pgrpm - pgrpm provides functions and operators to mimic rpm behaviour. This is espacialy useful if you want to sort row by version-release and take care of numeric values.
|Activity Percentile: 41.60
Activity Ranking: 74.00
Registered: 2005-03-23 20:29
|1. pgchem::tigress - Pgchem::tigress is the chemoinformatics extension to the PostgreSQL DBMS. It enables PostgreSQL to handle molecules through SQL statements.
|Activity Percentile: 12.80
Activity Ranking: 110.00
Registered: 2004-12-28 10:01
|2. Oralink - Oralink is a transparent gateway to access Oracle (tm) databases directly from PostgreSQL.
Can be used for integration , replication, or simply to access Oracle(tm) data using PostgreSQL .
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2004-11-02 18:07
|3. Search swish-e from PostgreSQL - Query swish-e index from PostgreSQL. This allows integration of search results from swish-e index and structured data from PostgreSQL.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2005-02-20 13:53
|4. Hyper Estraier search for PostgreSQL - This package consists of PostgreSQL C function which calls Hyper Estraier API and returns results in user defined format and trigger which maintains consistency of data in full-text index. It also include helper script to easily create full-text index.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2005-06-26 19:44
|5. OBELisQ - OBELisQ is a fork of PostgreSQL which enables intuitive, qualitative queries -- provide a few sample data points, and let the database find similar rows for you.
Interested parties should contact us for more information at firstname.lastname@example.com.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2005-09-03 08:34
|6. pgbash - Pgbash is a BASH shell which includes the functionality of accessing the database for PostgreSQL. It is possible to execute SQL by making a shell script in the batch processing, and execute SQL directly in the interactive environment.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2009-07-28 16:13


text:
Check out this list of freebies in honor of Veterans Day. Restaurants are honoring our past and present soldiers with free food. Some places have different dates and may require military id. Be sure to check if your local restaurant is participating. So be on the lookout for those details at the links below.
It's just a small way restaurants are saying thank you to our brave men and women.
Restaurant Freebies
Golden Corral: Free Buffet & Drink for Military (11/12 4pm-9pm)
Outback Steakhouse Free Bloomin Onion and Coke for Veterans Day
Texas Roadhouse: Free Lunch for Veterans
Texas Roadhouse: Free Lunch for Veterans
Little Caesars: Free Crazy Bread
{Related Posts}
FREE Money: $50 Bonus When You Open an ING Checking Account
Military Discounts at Lowe's, Home Depot and Old Navy


text:
OPEN MEETING with Dr. Jared Cohon, Chair of the Middle States Evaluation Team
Tuesday, March 25, 2014
3:00 to 3:45 PM
Kimmel Center for University Life, Room 905/907
Join Dr. Jared Cohon, Chair of the Middle States Evaluation Team while he visits NYU as part of its decennial re-accreditation. Open to students, faculty, and staff. The NYU Self-Study may be found here.
All faculty members are invited to celebrate the beginning of the spring semester with colleagues. Cocktails & hors d'oeuvres served.
Faculty are invited to bring their families to watch the NYU Men's and Women's Basketball games. Buffet lunch served between games, half-time shoot-out with prizes for kids, and the chance to meet the Bobcat.
All new faculty members are invited to meet faculty senators, new faculty colleagues, and other members of the NYU community.


text:
It's all to help people affected by Hurricane Sandy.
ShopRite has lowered the amount shoppers must spend in order to qualify for a free Thanksgiving turkey, according to Supermarket News.
The traditional ShopRite turkeyfest happens once a year. During that time, shoppers who spend a certain amount of money can pick up a free turkey for their Thanksgiving table.
This year, the supermarket recognizes that people who were affected by the recent hurricane probably didn't have food shopping on their minds - especially with areas of central New Jersey not having electricity, in some cases, for more than a week.
The free turkey threshold was $400. ShopRite has changed that to $300, Supermarket News reports.
The promotion, which runs from October 14 to November 22, requires Price Plus members to spend a qualifying amount to receive the free bird, or to take their pick from ham, turkey breast, kosher chicken, or other items.
Shoppers can pick their free bird up through November 22.


text:
Software Map
Tag cloud | Project Tree | Project List
Project tree
Now limiting view to projects in the following categories:
Development Status :: 5 - Production/Stable [Remove This Filter]
Operating System :: Microsoft :: Windows :: Windows NT/2000/XP/2003 [Remove This Filter]
Programming Language :: C# [Remove This Filter]
License > OSI Approved > BSD License
Browse By:
2 projects in result set.
|0. .NET 2.0 Member, Role, Profile Providers - Microsoft .NET 2.0 introduces new features around the 'provider' model, and ships with Membership, Role, and Profile providers that simplify management of user account information. This project ports these 3 providers to support Postgres.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2006-02-14 22:35
|1. PostgreSQL Data Access Application Block - An extension of Microsoft's Data Access Application Blocks for PostgreSQL. This project includes the NpgsqlDatabase and NpgsqlCommandWrapper C# classes that rely upon the Npgsql ADO.NET provider.
|Activity Percentile: 0.00
Activity Ranking: 0.00
Registered: 2005-05-20 21:08


text:
Max Payne 3's debut trailer
Here it is, the very first trailer for Max Payne 3. The long-in-development action game from Rockstar is coming out in March, and this video gives us a first look into how it's come along.
Yes, bald and bearded Max is still in the game, drinking his troubles away in Sao Paulo, Brazil. While the change of scenery may offend some fans, the return of Max Payne's incredible theme song, along with the noir-inspired narration, goes a long way in reviving our nostalgic memories of the first games.
You must be logged in to post.


text:
By Greg Roumeliotis
NEW YORK (Reuters) - Saul Steinberg, who led massive takeovers of companies before the titans of private equity popularized leveraged buyouts, and became one of the first personalities in finance to be dubbed a corporate raider, has died at the age of 73.
A lover of dealmaking, Steinberg rose to Wall Street prominence in the 1960s but ran into health and financial difficulties by 2000. His death was announced on Friday by CNBC, where his daughter-in-law Maria Bartiromo is a presenter.
Steinberg is survived by a wife and six children, including Bartiromo's husband Jonathan, the CEO of asset management firm WisdomTree Investments Inc
Born in Brooklyn, New York, in 1939, Steinberg graduated from the Wharton School of the University of Pennsylvania in Philadelphia at the age of 20 with an idea to lease IBM
In 1968, in a move more akin to the large deals seen today by the likes of buyouts firms such as Blackstone Group LP
A bid by Steinberg the following year to acquire Chemical Bank, a predecessor of JPMorgan Chase & Co
In 1984, he made an unfruitful bid for Walt Disney Co
One of Steinberg's most famous completed deals is Telemundo, which he formed in 1987 by acquiring Spanish language television stations. But he lost much of his assets with Reliance's demise in 2001.
A prolific art collector, Steinberg was a major donor to the Wharton School, where he served as chairman of its board of overseers.
In one his last deals that symbolized the ascendance of a new generation of dealmakers, Steinberg sold his apartment at New York's exclusive Park Avenue for a reported $37 million to Stephen Schwarzman, Blackstone's co-founder and CEO.
(Reporting by Greg Roumeliotis in New York; Editing by Carol Bishopric and Lisa Shumaker)


text:
Try the Season's Newest Hair Trends
Spring means renewal, so let these trendy cuts, styles, and colors inspire you to change up your own look.
By Natalie Gontcharova
Back Next
Getty Images
Long Bobs: Kristen Bell
The actress' shoulder-grazing hair is an easy-to-maintain length that flatters the face. Her subtle waves and honey highlights look effortlessly glam.


text:
Skip to main content
Note: This recipe is especially for kids with lactose intolerance, who need to limit or avoid dairy products.
This meal is a good source of protein and fiber. It tastes even better the next day!
Prep time: 20 minutes
Serves: 4
Serving size: 4 ounces of chicken and 1-1/3 cups of beans and rice mixture
Nutritional analysis (per serving):
355 calories
2 g fat
1 g sat fat
36 g protein
46 g carbohydrate
9 g fiber
66 mg cholesterol
558 mg sodium
58 mg calcium
3.8 mg iron
Note: Nutritional analysis may vary depending on ingredient brands used.
Variations and suggestions:
This can be served with yellow or brown rice. Consider sprinkling soy cheddar cheese over the top of this dish.
Reviewed by: Allison Brinkley, RD, CNSC, LD/N
Date reviewed: July 2012
Note: All information is for educational purposes only. For specific medical advice, diagnoses and treatment, consult your doctor.
© 1995–2014 The Nemours Foundation/KidsHealth. All rights reserved.
Find out by selecting your child's symptom or health condition in the list below:
Download Summer 2014 (PDF)
The 30th annual Miracle Makers fundraising special aired on KOMO 4 TV on June 6, 2014. The special takes us on a journey through the hopes, fears, victories and challenges facing patients at Seattle Children's. Cosponsored by Costco Wholesale and KOMO 4.
In the spirit of the holidays, patients, parents and doctors share inspirational stories of healing and hope. From surviving heart failure and a near-death drowning to battling a flesh-eating disease, witness how the impossible became possible thanks to the care patients received at Seattle Children's Hospital.
Miracle Season, hosted by Steve Pool and Molly Shen, aired Dec. 8, 2013, on KOMO 4 TV. The annual holiday special celebrates the remarkable lives of Seattle Children's patients.
Seattle Children's provides healthcare without regard to race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry) or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.
© 1995-2014 Seattle Children's Hospital


text:
Supar Tom
'Toad coin?' wondered the traveler as he examined the pebble. It did not look all that different from any other pebble, and certainly nothing like a coin. 'What manner of coin has no head or tail, and bears no seal or flag? Who backs this toad coin, the toad bank? The toad treasury!?' The traveler laughed, but the toads croaked sternly back at him.
Spending $10-15 a day on perishable organic dog food is not a sign of a decadent culture in terminal decline, it's actually real good and worth it.
The guyz go through their 21 year history of their own special brand of gaming journalism.
No lifeguard on duty. Maze run at your own risk.
The Comedy Goldmine examines the funniest and most creative threads from the Something Awful Forums. Although the Comedy Goldmine has changed authors many times over the years, its focus on the Something Awful Forums is still the same. Includes hilarious Photoshops, amusing work stories, parodies, and other types of oddball humor.
Copyright ©2014 Rich "Lowtax" Kyanka & Something Awful LLC.


text:
Finding Dr Right
What makes a good vet?
Please note comments are moderated. After being approved your comment will appear below.
Submitted by Lucy | September 19 2013 | Permalink
Our vet appreciates it when I have done some Internet or other research and ask questions based on that, rather than getting offended that I've not relied on him exclusively. He is also very warm and engaging with both my dog and me (my dog is highly reactive, and my vet is very understanding).
Submitted by Cherie Mathis | September 19 2013 | Permalink
I have been fortunate to find a vet that my pug and I both are happy with. He is very attentive to Casey. He walks into the room smiling and speaks to both of us, not just me. I can tell he really likes and cares about Casey. That means so much to me because I know he will do his very best to take care of him. The office staff is always very nice and welcoming which is also a nice bonus.
Submitted by Colleen | September 19 2013 | Permalink
I want a vet who sincerely has an affection & affinity for animals, who greets my dog as s/he greets me, who listens to my concerns, answers my questions thoroughly, doesn't make me feel pressed for time or sees us as a $ first. Am currently going through terminal cancer with my pup and our vet had to send us out to a specialist for ultrasound needle guided biopsy - the difference between the two practices was night and day - pressure for surgery/chemo/radiation with the specialist, who never once looked at my dog during our discussion, never once addressed my dog by his name - only talked $ for surgery. I had to bring up the questions about life span, quality of life, effects of the surgery/chemo/radiation. It was horrific in so many ways (and that specialist called me twice after the diagnosis to apply pressure). After getting the results, I made a teary visit with our regular vet and he was the one that explained so much more, all the while, petting my dog and handing me kleenex. He's gone beyond strict medical care by asking me to make a list of my pups 5 best things he loves to do and each time we meet (every 90 days for tests), he reviews that list with me (does my pup still greet me at the door with a bark & a wag? does he still love to go on walks? car rides? to the dog park? does he love to eat?) as his belief is that when you can only answer yes to one or two of those traits, it's time to say goodbye and by making this list BEFORE they start happening, it's much easier for both of us to know. I loved that and it gives me confidence that he not only knows what he's doing & has been through this so many times, but that he cares for my pup. He's also shared that no matter how many times this happens, he's never gotten use to it and that it gets harder as he gets older. It let me know truly how human he is and how much is patients matter to him. Love him!
Submitted by Stefanie H | September 19 2013 | Permalink
I have an exceptional vet. After using a different vet that we wound up disliking we are now at the practice that everyone recommended. The owner of the practice is very beloved in the area & someone donated money to his alma mater to have a wing named after him after he saved their dog. He is an early adopter for new techniques as well. When he added a holistic vet to the practice she became our vet when no one else was available for an emergency visit. Since she liked me the receptionist always schedule us with her. What I like most about her is that she uses a combination of traditional & holistic veterinary practices. She is also an acupuncturist, which has been a god send for our collie with bone degeneration in his spine & arthritis in his hips. She keeps copious notes & will even sleep at the hospital if there is a patient she's worried about. She has even been known to stay in the cage with the animal if necessary. She also starts each physical exam by taking a full history even if it is a patient she sees regularly, and the care is constantly tweaked since she is always studying so she can provide the best care possible.
Submitted by Marcella Congdon | September 19 2013 | Permalink
Personable towards dog & me, able staff, clean offices, etc. all obvious. Thorough examinations and good diagnostic skills, absolutely. But the wise vet who can understand not overmedicating, not just routinely vaccinating a dog with "issues", willing to do titers to determine need for vaccines, willing to temper treatment to the dog not just the calendar ... that's the vet I'll return to.
Submitted by Jen Brighton | September 19 2013 | Permalink
We have been with the vet of our dreams since we acquired our prior dog, Mocha, a hyper Lab-boxer mix. He held our hands through two ACL surgeries, two dog bites that required stitches when she was a puppy, and end of life cancer that we eventually learned was in her heart ventricle where he had to drain the fluid from her body on numerous occasions. He was with us at the end when she was too ill to keep going at the ripe age of 14. He has continued to care, along with the other veterinarians in his office, for our 3 kitties and 2 pit bull mixes.
First and foremost what we love about Todd is his genuine affection, care and liking for the animals he works with. He gets down on the floor and hugs them if they are comfortable with that, lets them lick his face and talks to them before any examinations or procedures. Hand in hand with that is his reputation locally as an excellent surgeon. His father is a well-respected veterinarian who, with another vet, founded the business, and he has more than filled his father's shoes. He even lets his dad still work in the office and his sister has worked there as long as I can remember. There is no turnover of staff, which also says a lot. He has not charged me for well check evaluations required for my therapy dogs as he said I'm volunteering my time.
While there are many, many worthy veterinarians in my city, some of whom are my friends, I don't know what we would do without Dr. Todd Perry.
My most recent favorite Dr. Todd tale was when I took my dog, Inca, in for a checkup. The day before, she and my other dog, Domino, had discovered an old slug trap in the strawberries filled with sour beer and rotten slugs. Unbeknownst to us they (delightedly I'm certain) rolled in it. It was the most revolting smell my husband and I had ever encountered and we actually thought they had gotten into human feces. Keep in mind these dogs sleep in the bed. When I warned Todd not to hug Inca this time and told him what she had done and that we hadn't been successful in getting the stink off her, he got down on the floor, hugged her, looked into her eyes and said, "Good dog, Inca!" In other words, way to act like a dog.
What more can I say? I could write a book about Dr. Todd Perry and the other veterinarians at Fountain Veterinary Hospital.
Submitted by Amy Ruppert | September 19 2013 | Permalink
* A great diagnostician
Submitted by Hannah Rose Ber... | September 19 2013 | Permalink
What makes the perfect vet? I say it's all about how they treat my pets.. No owner likes watching their dog cower behind them, as unknown and frightening fingers reach out to drag them away. I have personally been behind the doors that haunt our pet's dreams, and it's actually quite easy to pick out the vets that treat their patients like part of their family. I'm happy to say, that the veterinary clinic I visited and observed left me thinking that the animals getting treated there were infact, in good hands. That's what every pet owner should be able to think. These characteristics are especially important for when pets are being boarded. I want my dogs Aurora and Lucky to always be safe and protected when we have to leave them in the last place they'd like to be. I want my veterinarian to understand their fear and try their best to make them feel comfortable. We recently changed clinics and I'm extremely glad we did, because our last one seemed to be soulless. They would tug at my dogs' leashes with way more force than necessary making them gag, and acted as if my best friends were just another chore. It made my blood boiI. It was impossible to enjoy my two day escape to paradise, because I couldn't stop thinking about my Lucky and Aurora spending their weekend in a prison. Whenever I closed my eyes, Aurora's desperate attempts to free herself from the heartless creatures that held her back, flashed before me like images running across a movie screen. Play, rewind. Play, rewind. An endless cycle that did not fade until my babies were back home, safe and sound. We have taken the time to make sure this never happens again, and thankfully it hasn't. These days, I leave for vacation knowing my pets will be with kind, repectful, caring veterinarians, who love them almost as much as I do. I know I've found the perfect vet. I hope many others can say the same.
Submitted by Pauline | September 19 2013 | Permalink
I have the perfect vet but I interviewed several when I moved to the area and then chose. I want my vet to be AAA approved, have more than two vets in the office including some younger ones, and kind vet techs. I want a vet that is conservative and does not try to sell you the most expensive and latest thing, or procedure to start, my vet explains everything and supports my decisions and most important spends time with me and the dogs, a vet has to be kind, patient and caring and good with his employees. I want a vet that works WITH me to make decisions, I do dog rescue and my vet knows the costs, the dog issues and the problems rescues deal with, he is also very supportive of the local shelters in our area. I am blessed here in western MA.
Submitted by jeanne brase | September 19 2013 | Permalink
Our vet is fabulous he not only makes us feel good he is so caring tender as a doctor and doesn't want to add undue costs onto our bill that aren't necessary. Even really important his tender ways with our animals, is extremely important to us that he doesn't scare them. I have two dogs yet my german sheperd/chow is like me not one whom likes to go to a doctor however, he always says how calm, quiet, and sweet she is and i tell him and his very kind staff that they are so absolutely gifted in that they were meant to work with animals.
Submitted by DJ | September 19 2013 | Permalink
What I want in a vet is similar to what I want in a doctor. Someone with good medical skills, who keeps up to date, and who is very open to answering questions. For a vet is also helps if he/she understands that "pet parents" are very intense about their pet's well-being. Sometimes I have found a good vet by asking around but other times I just had to try a couple to find out.
One vet I went to told me to just ignore a lump on my dog's leg and I wasn't comfortable with that. I went to another vet who took a biopsy and discovered cancer. So there are vets out there with nice "bedside manner" but who are pretty incompetent.
One additional thing: My current "vet" is really a practice full of vets who can be contacted online and with very nice, responsive office staff.
Submitted by JIM fREEMAN | September 19 2013 | Permalink
Submitted by Madeline Davis | September 19 2013 | Permalink
Our second dog Harley, is a rescue. He was one of twenty dogs chained to trees, poorly nourished, unsocialized and most had hearth worm. SNIPPP, a rescue group in Burney, Ca, was willing to pay the vet bills. We were living in San Jose,Ca at the time. Our vet of 17 years was going to charge over $3000 for the heart worm treatments.SNIPPP put us in touch with a vet in Shinletown,Ca, Dr Lydon. He charged 1/10th what the San Jose vet was going to and completely understood what Harley needed medically and emotionally. Instead of being crated 24/7 to keep him calm, he was laying down with the office staff getting love and attention. Today, four years later, Shingletown is our permanent home. When we visit Dr. Lydon., he sits on the floor, kicks back and talks to me. This lets Harley get use to the different environment
Submitted by Dorothea Pond | September 19 2013 | Permalink
It makes sense to have clinics with more than one vet to share overhead, etc., but I am happy that we have found a clinic like that such that we could experience the different vets until we found the one we preferred. And this clinic is to our liking because we aren't told to make an oppointment and accept the vet we get. Now that we have a preference, we can have our dog treated by only the vet of our choice. I think consistent health care by a doctor who knows the patient well is as imporant for dogs as it is for humans.
Submitted by jen richards | September 19 2013 | Permalink
i just wanted to give my opinion on what makes the perfect vet. yes, while getting us in the same day is important, the most important thing when it comes to a vet is trust. i want to know that they have eugene and olgas best interest in mind. i also like a vets office that is clean and easy to get to , or somewhat close to home.
Submitted by Reva Laituri | September 19 2013 | Permalink
When my husband I got our first dog, there were two clinics in our town. The puppy we adopted at six weeks became deathly ill within the first 48 hours of bringing her home. The clinic we went to did not want to keep her at the clinic (she was severely dehydrated), said they didn't know what she had but that it appeared to be related to cat distemper, gave me some medication to hopefuly control the vomiting and diarhhea, and said she would probably die. We later figured she was probably one of the first parvo cases in our area. I was determined she was not going to die and did everything I could to see that didn't happen. She lived and we had another 15 years together until she lost her fight against cancer. Needless to say, we switched to the other clinic. I had no complaints with that clinic and was a client for many years. They gradually expanded and hired a couple more vets. Which brings me to Dr. Scott Jandron.
He was fresh out of school the first time I saw him for one of my dogs. At the time I had three older dogs that had a multitude of health issues. One had Cushings Disease, heart block and other problems. The other had diabetes that was hard to control with complications of glaucoma, blindness, seizures, etc. He went above and beyond in caring for them, often researching new treatments and drugs, and calling me to see how they were doing. At the same time, my brother started going to him with his dog who had developed a tumor on his leg, which had to be amputated. Dr. Jandron, called my brother at home to see how Tuffy was doing...while his wife was in labor giving birth to their first child! After a few years, he left that clinic to open his own. For a short period of time he was without a clinic but would still take my calls at his home and see my dogs. When the time came to euthanize one of them, he came to my house. It's now been over 20 years and he has seen my current animals their whole lives. He knows them, remembers their histories, and cried with me when last December Gracie was euthanized in the end stages of kidney failure.
What do I like about him?
1. He remembers all my animals, past and present.
I consider myself very fortunate to have such a kind, trustworthy,and dedicated vet to care for my dogs. He often laughs now when I ask about the prognosis on any medical issue because he said my dogs throw all the statistics out the window and recover more quickly, respond to treatments better, and outlive predicted outcomes. He credits me with much of it, but in my book, it is all him. He consistently gives me all the tools I need to do everything within my ability to give my dogs what they need. I am grateful he is substantially younger than me because hopefully that means I will never have to look for a new vet. I would have a high regard for him if he only did half these things. That he does so much more, makes him truly exceptional.
Submitted by Jane Brydon | September 20 2013 | Permalink
I tried many vets until I found the one that I now use. I chose Dr. Rose DiLeva because she practices non-traditional medicine as well as traditional veterinary care, which was extremely important to me. She offers acupuncture, Chinese herbs and other natural products. Her vaccines don't contain mercury. I learned the importance of this because she takes time explaining things to me. She is compassionate and caring with both owners and pets. I also like the fact that I am scheduled so that I am not waiting in a waiting room full of other animals, I am taken right into an examining room and seen shortly thereafter. I really like the small practice atmosphere. I went to a large practice and never knew which vet I was going to see and no one knew me. I went to a practice where the vet was afraid of my large, very kind and well trained Rottweiler. I went to a small practice that I really liked, but I really wanted someone who would offer both traditional and non-traditional methods. I feel I have found it all with Dr. Rose.
Submitted by Dori Aravis | September 20 2013 | Permalink
Compassion more than anything else, and knowing that your pet is a part of your family, I had an Alaskan malamute who had liver cancer. The vet said "you might as well put him down now on the table since he won't survive". I said no and took him home. I felt what he did was heartless to say the least, and I stopped
Submitted by C. Scharfeld | September 20 2013 | Permalink
I look for compassion and a willingness to work with me, not just tell me what to do. I was very fortunate to have great vets in Jacksonville and have found another great one in Tampa. They communicate openly and don't have a problem with me when I question something or disagree.
Submitted by Cynthia | September 20 2013 | Permalink
I want a vet I can trust, and who will work with people that can't afford procedures, and that you can tell animals are their number one priority. I used to have a vet where I used to live in Jackson, CA who was the best, she would take payments, she would come to your house if necessary, no charge. She would charge cost only to people that could not afford something, never met anyone so dedicated. That is a great vet!
Submitted by Cheryl | September 20 2013 | Permalink
They need have a clean facility and be current with behavior and using positive methods in which case I know they will be gentle with my dogs. They also need to keep updated with equipment and training. I also want a place that practices alternative medicine along with conventional.
Submitted by Janet Harlan | September 20 2013 | Permalink
For me the perfect vet shows empathy to the owners and total commitment to the animals. Our vet, Dr. Kim Robinson, at Catawba Animal Hospital in Rock Hill. SC is perfect. She is always there for us. Available even after office hours if we have questions or an emergency. She is a friend, an expert, a counselor. She clearly explains the options and never makes you feel bad if you can't go with the most expensive choice.
Submitted by Alice Moore | September 23 2013 | Permalink
Years ago I had a dog with an attitude problem. He was fearful and defensive. When he was less than a year old he growled at the vet when she approched him during a house call. We had had him since he was a fur ball.
Submitted by Joe | September 28 2013 | Permalink
Our favorite vet shows great compassion for our dogs. You can see that he cares. We've developed a level of trust with him and he knows that if we bring the dogs in for something he needs to pay attention and we are not (usually) being hypochondriacs. He will take the time to explain and communicate so that we understand the issues and are informed on the decisions we have to make. When he says "I would do X if this is my dog" we know that he has the animal's best interests at heart. He is Dr. Adams in Colorado Springs.
Submitted by Sheri Lattimore | September 29 2013 | Permalink
Please remember that my time is valuable too. I don't want to wait at the counter to check in, then wait for a room, then wait in the exam room and finally wait at the counter again to pay. Last trip to my previous vet entailed a 40 minute series of waits for a 7 minute exam.
Submitted by Anonymous | November 18 2013 | Permalink
I was disappointed by what I thought was a "perfect" vet. Let's remember that veterinarians are busy people and do make mistakes. They often backup other vets within their facility even if they know something went a muck. Foremost above all else, be proactive and use your own instinct when it comes to your dog. This is why I like the BARK!
More From The Bark
More in Guest Posts:
Copyright © 1997-2014 The Bark, Inc. Dog Is My Co-Pilot® is a registered trademark of The Bark, Inc


text:
Rookie quarterbacks, a veteran QB returns, as do some star runners, a breakout star receiver in the making and more in Scott Cullen's Week One NFL Round-up.
IMMEDIATE IMPACTFor years, it has been easy to dismiss the contributions of rookie quarterbacks, knowing that they would take their lumps for most of their first season (if not longer) before they were productive enough to be counted on every week. After Cam Newton, and to a lesser extent Andy Dalton, last season, there is at least some reason to think that rookie quarterbacks can step in an play a productive role right out of the gate.
While most first-year quarterbacks struggled Sunday, Washington QB Robert Griffin III was a different story. He torched the New Orleans Saints (19-for-26, 320 yds, 2 TD, 10 carries, 42 yds), justifying the hype that had surrounded him in training camp. It's true that the Saints don't have a vaunted pass defence, ranking 30th in passing yards allowed last season and they were missing starting corner Jabari Greer, but that was an impressive debut and Griffin's talent raises the bar for Washington receivers.
Pierre Garcon made his Redskins debut a success with four catches for 109 yards, including an 88-yard touchdown, before suffering a foot injury that knocked him out of the game before the end of the first quarter. If Griffin III has starter value in fantasy, so too will Garcon.
DOWN ON HIS LUCKIndianapolis rookie QB Andrew Luck had a more difficult debut (23-for-45, 309 yds, 1 TD, 3 INT) facing the Chicago Bears at Soldier Field. Luck connected with predictable targets -- veteran WR Reggie Wayne (nine catches, 135 yds) and rookie TE Coby Fleener, his college teammate, (six catches, 82 yds) -- along the way, but there were a lot of incomplete passes when he tried to throw downfield. It took 18 targets for Wayne to register nine catches, for example.
HEY MANNING, NICE SHOTAfter a year on the sidelines and four neck surgeries, Broncos QB Peyton Manning looked pretty sharp against the Pittsburgh Steelers Sunday night, completing 19 of 26 passes for 253 yds and two touchdowns. Manning targeted wide receivers Demaryius Thomas and Eric Decker seven times each, splitting ten catches evenly between them, but Thomas' big-play ability was in evidence again as he caught a 71-yard touchdown on a wide receiver screen, allowing him to finish with 110 yards for the game, while Decker contributed 54 yards.
RETURNING RUNNERSAfter all the talk about Maurice Jones-Drew being a third-down back in the opener, following his contract holdout, Jones-Drew accumulated 95 yards on 22 touches against the Vikings. Rashad Jennings had nine touches for 40 yards, so it's pretty clear that MJD is the already the primary ball carrier.
Just as the Jaguars welcomed back Jones-Drew, the Vikings got Adrian Peterson back from knee surgery and Peterson was in fine form rushing for 84 yards and two scores on 17 carries.
BREAKOUT STARComing into the season there has been a lot of hype surrounding Falcons second-year WR Julio Jones, who is expected to emerge as a star in the Falcons' passing attack. While I expect a good season from Jones, my Week 1 Rankings had him ranked lower than most, so when he put up a big game in Kansas City (six rec., 108 yds, 2 TD) it deserves recognition. There were extenuating circumstances, however. Part of the reason that I was hesitant to give Jones a high ranking going into the week was that I like Chiefs CB Brandon Flowers and thought his coverage skills could limit the Falcons' passing game, even with top pass-rusher Tamba Hali sitting out a suspension. However, when it was announced Sunday that Flowers' foot injury would keep him out of the opener (after taking first-team reps in practice), that opened the door to a big game for the Falcons. It might have been coming anyway, but Flowers' absence was a factor.
HOLD OFF ON THIS BREAKOUTIn camp, there was no shortage of praise for second-year Chiefs WR Jon Baldwin, a big target who was expected to make a difference in the red zone, but of 20 passes directed to Chiefs wide receivers against Atlanta, none went in Baldwin's direction. Dexter McCluster, on the other hand, was targeted 10 times, catching six for a team-leading 82 yards.
EAGLE EYEEagles QB Michael Vick endured a rough day at Cleveland (29-for-56, 317 yds, 2 TD, 4 INT) to start the season. There is an element of risk involved in Vick because of health, but if he's turning the ball over -- he threw a career-high 14 interceptions last season (after 21 touchdowns and six interceptions the year before) -- then it's going to affect the Eagles week-in and week-out. Vick completed 15 of 30 attempts to wide receivers Jeremy Maclin and DeSean Jackson.
BAD NEWS BROWNSThe Cleveland Browns had a fresh start with a rookie quarterback and rookie running back but, even though they led for a significant portion of the game, their production wasn't positive against Philadelphia. QB Brandon Weeden (12-for-35, 118 yds, 4 INT) couldn't move the ball and their star running back, Trent Richardson had 19 carries for 39 yards. With the running game shut down, Weeden had trouble finding the mark downfield.
He completed five passes (on 12 attempts) to wide receivers Mohamed Massaquoi and Josh Gordon (another rookie), but Greg Little was kept off the board entirely, no catches on four targets. Not every team is going to have Nnamdi Asomugha and Dominique Rodgers-Cromartie on the corners, but the wide receivers have to be utilized more efficiently for the Browns to be competitive.
MOSS SCORES49ers WR Randy Moss, also playing a prominent role after sitting out the 2011 season, caught all four passes thrown his way in Green Bay, finishing with 47 yards and a touchdown. The Niners' don't have the most prolific passing attack and Moss is going to share targets with TE Vernon Davis and WR Michael Crabtree, but a starter with his credentials (over 14,000 yards, 149 TDs) shouldn't be ignored.
MORE REDSKINSWith Garcon sidelined, Aldrick Robinson (4 rec, 52 yds, 1 TD) emerged as a contributor for the Redskins.
While it's a fool's game to try and guess which direction Mike Shanahan will go with his running game, the immediate leader in Washington's competition is Alfred Morris, the rookie from Florida Atlantic, who had 28 carries for 96 yds and two touchdowns against New Orleans. With Morris in the primary role, Evan Royster and Roy Helu combined for seven touches between them.
OTHER ROOKIE QBsMiami's Ryan Tannehill had a predictably tough day (20-for-36, 219 yds, 3 INT) at Houston. His most success came with short passes to RB Reggie Bush (six catches on six targets for 46 yardS) and slot receiver Davone Bess (five catches on seven targets for 45 yards).
While Legedu Naanee started at wide receiver for the Dolphins, he was only targeted twice (zero catches), leaving Brian Hartline (eight targets, three catches) a more prominent role.
Seattle QB Russell Wilson wasn't awe-inspiring (18-for-34, 153 yds, 1 TD, 1 INT) at Arizona, but he could have emerged on the right end of the scoreboard if WR Braylon Edwards had been able to snare a last-minute pass in the end zone. Wilson remains a wildcard, to some degree, with more upside than Tannehill, for example but, after one week at least, he's not yet a star.
SAINTSWhile an upset loss at home was hardly what the Saints were looking for, they did get a big day from WR Lance Moore (6 rec, 120 yds, 1 TD) and, on defence, second-year DE Cam Jordan (11 total tackles) was much more involved that he was as a rookie, when he finished with 31 total tackles in 16 games.
NOT SO FAST, YOUNGComing into the year, one of the more popular breakout receivers was thought to be second-year Lions WR Titus Young, who had scored four touchdowns in the last four games of the 2011 season, but his ascent to stardom has to wait for at least another week after he was benched by the Lions for head-butting Rams CB Janoris Jenkins.
Young finished with one catch (three targets) for 14 yards and one rush for 11 yards, but QB Matthew Stafford still had plenty of receiving options at his disposal, directing 33 of his 48 total passes to wide receivers Calvin Johnson and Nate Burleson as well as tight ends Brandon Pettigrew and Tony Scheffler.
RUNNIN' RIDLEYThe New England Patriots made some interesting choices in their 34-13 win at Tennessee. For one thing, RB Stevan Ridley had a huge game (152 yards and 1 TD on 23 touches), while slot receiver Wes Welker was targeted just five times, finishing with three catches for 14 yards. Considering Welker ranked second in the league in targets last season, falling behind Brandon Lloyd and both tight ends (Rob Gronkowski and Aaron Hernandez) in targets for Week One counts as a little eye-opener.
CJ2KComing off the least productive season of his career which, admittedly, still brough 1465 yards from scrimmage, Titans RB Chris Johnson was locked down by the Patriots defence, finishing with four yards on 11 carries to go with 47 yards on six receptions. It's not worth panicking about Johnson already but, as poor as he performed last season, he finished with fewer than 51 yards only twice (Week 10 at Atlanta, Week Six vs. Houston).
ANOTHER C.J.Bills RB C.J. Spiller (194 yards, 1 TD, 16 touches), who was expected to see an increased role anyway this season, rose to the occasion when Fred Jackson (six carries, 15 yds) suffered a knee injury on a hit by Jets SS LaRon Landry. Spiller has more breakaway ability than Jackson and finished with more than 100 yards from scrimmage in four of the last five games last season.
JETS' AERIAL ATTACKIf there is ever a need to write off the value of preseason football, the New York Jets did their best to provide it in Week One, with an effective passing offence against the Buffalo Bills, despite looking completely lost offensively before the season kicked off for real.
QB Mark Sanchez (19-for-26, 266 yds, 3 TD, 1 INT) was steady and productive and might have a few emerging talents on the perimeter. Veteran Santonio Holmes will play a big part in the Jets' passing game, but second-round pick Stephen Hill impressed with five catches for 89 yds and a pair of touchdowns. Hill is a 6-foot-4 burner (4.3 40-yard dash) who adds a downfield element that the Jets didn't have last season when Plaxico Burress, and his loping strides, were across from Holmes.
Second-year slot receiver Jeremy Kerley also had a productive game (four catches, 45 yds, 1 TD; one punt return TD) against the Bills and if the Jets have these options in the passing game, then Sanchez should hold a decided advantage in the quarterback competition with Tim Tebow, whose total contribution on Sunday was 11 yards on five carries.
HOPE FOR GABBERTWhile the Vikings' secondary isn't outstanding, by any means, there is some reason for the Jaguars to be optimistic about their offence. Second-year QB Blaine Gabbert, who was overwhelmed as a rookie, completed 23 of 39 passes for 260 yds and two touchdowns -- his best game as a pro.
RUNNING IN PLACEWith Panthers RB Jonathan Stewart on the shelf with an ankle injury, it appeared that DeAngelo Williams would be in line for a productive game at Tampa Bay. After managing four yards on seven touches, that wasn't quite the case. The Panthers couldn't generate any kind of running game (10 yards on 13 carries), which means credit is due to the Bucs' defence. MLB Mason Foster, DT Gerald McCoy and FS Ronde Barber combined to accumulate seven tackles for loss.
On the other hand, Bucs rookie RB Doug Martin put up 118 yards on 28 touches.
PACKERS SPREAD OFFENCEQB Aaron Rodgers isn't afraid to share the ball and it doesn't matter where the receivers fit on the depth chart. James Jones & Randall Cobb (Nos. 3 and 4 on the depth chart) combined for 13 catches and 158 yards against San Francisco, while the top two, Greg Jennings and Jordy Nelson finished with 10 catches for 98 yards.
Cedric Benson was the only running back to get carries for the Packers, managing 18 yards on nine carries.
OGLETREEIt happened on Wednesday, so this is hadly news, but Cowboys WR Kevin Ogletree had a breakout game (8 rec, 114 yds, 2 TD) against the Giants to start the year. With WR Miles Austin hurting and TE Jason Witten not nearly at full strength as he played with a lacerated spleen, resulting in a much bigger role than anticipated. Prior to Wednesday's performance, Ogletree's previous career-high for yardage in a game was 50 (on two catches in Week Two last season).
Now, Ogletree isn't going to be a primary target for the Cowboys all season, nor will he be facing an injury-depleted secondary like that of the Giants each week. Nevertheless, there is a role for Ogletree to fill, just as Laurent Robinson did for the Cowboys last season. In deep leagues, that might be enough to make Ogletree appealing but, in many leagues, he has probably already been scooped off the waiver wire after a starring performance in a nationally-televised game.
INJURIESJets CB Darrelle Revis - concussionTtians QB Jake Locker - left shoulderCardinals QB John Skelton injured - ankleRams T Rodger Saffold - neckTitans MLB Colin McCarthy - ankleBills WR David Nelson - kneeColts OLB Dwight Freeney - ankleBears CB Charles Tillman - legSaints WR Devery Henderson - concussionEagles WR Jeremy Maclin - hip
Scott Cullen can be reached at email@example.com and followed on Twitter at http://twitter.com/tsnscottcullen. For more, check out TSN Fantasy on Facebook.
Alex Marvez of Fox Sports 1 joins the show to discuss Jim Irsay, Michael Sam, and J.J Watt.
WKYC Cleveland's Matt Florjancic joins Andy McNamara and John Letherby on Game Night.
Pro Football Hall of Fame VP of Communications Joe Horrigan joined Game Night with Jim Tatti & Andy McNamara to talk NFL Hall of Fame Weekend
Buffalo Bills at Houston Texans - 1pm et/10am pt (CTV Toronto, CTV Kitchener, CTV Ottawa, CTV Northern Ontario, CKPR)
Green Bay Packers at Chicago Bears - 1pm et/10am pt (CTV Vancouver, CTV Alberta, CTV Saskatchewan, CTV Winnipeg, CITL)
Detroit Lions at New York Jets - 1pm et/10am pt (CTV Montreal, CTV Atlantic)
Carolina Panthers at Baltimore Ravens - 1pm et/10am pt (TSN2)
Philadelphia Eagles at San Francisco 49ers - 4:25pm et/1:25pm pt (CTV Toronto, CTV Kitchener, CTV Ottawa, CTV Northern Ontario, CTV Montreal, CTV Vancouver, CTV Alberta, CTV Saskatchewan, CTV Two Atlantic, CKPR, CITL)
Atlanta Falcons at Minnesota Vikings - 4:25pm et/1:25pm pt (TSN2, CTV Winnipeg)
New Orleans Saints at Dallas Cowboys8:15pm et/5:15pm pt (TSN1, TSN3, TSN4, TSN5)
New England Patriots at Kansas City Chiefs7pm et/4pm pt (TSN1, TSN3, TSN4, TSN5)
NFL on TSN Broadcast Schedule


text:
News from WTOP
News from the AP
Mike Causey
Shows & Panels
Shows & Panels
Shows & Panels
Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- CDWG/NetApp
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- Government Perspectives on Mobility and the Cloud
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Mitigating Insider Threats in Virtual & Cloud Environments
- Modern Mission Critical Series
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Reimagining the Next Generation of Government
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
Search Result
Search Tags: living wills
Personal care contracts and financial road maps
Hosts Bob Leins and Tammy Flanagan are joined by life coach Michael Townshend who will answer your questions about personal care contracts...and what you need to do to plan for your retirement.
May 9, 2011
Tags: pay and benefits , personal care contract , Carpe Diem Coaching Inc , Michael Townshend , financial road map , retirement , For Your Benefit , Bob Leins , Tammy Flanagan , retirement benefits
Lifelong Learning and Your Future Care
This week, hosts Bob Leins and John Elliott talk with retirement and career expert Mike Townshend. Tune is as they discuss two separate topics: lifelong learning and future care.
September 13, 2010
Tags: For Your Benefit , Bob Leins , John Elliott , lifelong learning